Oliver Wyman Health Innovation Summit 2019

Marcus Betts grew up in the North Lawndale Community on Chicago’s West Side and currently serves as the Assistant Vice Chancellor for External Engagement at the University of Illinois at Chicago. Betts' responsibilities have expanded to include a strategic focus on elevating and promoting the University of Illinois Hospital and Health Sciences System (UI Health). He also facilitates connections that strengthen and build partnerships while developing and maintaining key relationships with external stakeholders, associations, corporations and institutions. In his role, Betts advises UIC’s senior leadership on a variety of community matters.

Kate Brown leads Mercer's Center for Health Innovation (CHI), a group of specialists within Mercer’s US Health business dedicated to driving innovation that works for our employer clients. Key focus areas include the changing landscape of healthcare networks, the role of the consumer, the explosion of point solution vendors, and the role these vendors will play in the future of healthcare. Prior to CHI, Brown served as a Total Health Management consultant. In this role, she developed well-being strategies for large employers, and did extensive project management, including large-scale implementations, and ongoing vendor management. She started her career in sales and operations at Apple, where the notion to “think different” took hold – a mindset that serves her well in her current role as the CHI leader. Brown holds a master’s degree in Kinesiology from the University of Texas, and the CEBS designation.

Renee’ Buckingham is President, Care Delivery for Humana. Humana’s Care Delivery Organization includes Partners in Primary Care – Humana’s wholly owned, de Novo senior-focused, payer agnostic primary care clinics, Family Physicians Group a large primary care group located in Orlando, FL., Transcend MSO, and various provider joint-ventures and partnerships. As President, Renee’ is responsible for business operations, profitability and national expansion of these Primary Care businesses. Until January 2018, Renee’ was Vice President and North Division Leader, in Humana’s Medicare business where she led Market Operations for one of Humana’s largest Divisions. Prior to joining the Medicare Segment in October 2014, Renee’ led Humana’s Provider Development Center of Excellence as an Enterprise Vice President and was responsible for both building and deploying programs and capabilities designed to support providers as they move from transactional care to value-based care. Under her leadership, Humana grew Value Based Agreements to more than 900 Accountable relationships. In late 2015, Renee’ was named Humana’s Medicare Business Integration Leader representing Humana in pre-integration efforts with Aetna. Renee’ has been with Humana for 20 years and held several other leadership positions including Vice President, Provider Contracting, Regional Vice President Provider Contracting and National Vice President, Provider Engagement and Value-Based Programs.

Paul Ciechanowski, MD, MPH, has spent over a decade conducting NIH- and CDC-funded clinical trials in developing and testing collaborative care programs as a comprehensive intervention for treating behavioral health issues in primary care. He and his colleagues modified the original intervention to extend beyond addressing behavioral health to treat patients with diabetes, heart disease, epilepsy and other conditions. Dr. Ciechanowski founded Samepage Health, a company that provides software and services to enable the deployment of collaborative care in value-based and fee-for-service settings. He has implemented collaborative care programs in the US, Canada, and India. He has authored over 100 scientific papers and book chapters. Dr. Ciechanowski earned his medical degree from McGill University in Montreal, Canada, and completed residencies in family medicine (UBC) and psychiatry (UW). He recently served as president of the Community Leadership Board for the American Diabetes Association in Washington State.

Christopher Chen, MD is the Chief Executive Officer of ChenMed, an innovative primary care practice that aims to be America’s leading primary care provider, transforming care of the neediest populations. ChenMed provides no-fee, concierge-style care for polychronic, low- to middle-income seniors. Working exclusively through a full-risk capitation model in Medicare Advantage, Dr. Chen has grown ChenMed more than 30% per year. Now operating in 15 metropolitan areas, ChenMed has been unique in its ability to scale a successful primary care practice. Dr. Chen has guided ChenMed to industry-leading quality and patient satisfaction results and 30-50% reductions in hospitalization rates. Raised in South Florida, Dr. Chen graduated from the University of Miami’s Honors Program in Medicine, followed by a residency at Beth Israel Deaconess, a Harvard University teaching hospital. He also completed a cardiology fellowship at Cornell University Medical College in New York. He still sees patients at the Miami Gardens clinic.

Aneesh Chopra is the President of CareJourney, a Hunch Analytics company that provides actionable, clinically-relevant analytics services to population health organizations. He served as the first US Chief Technology Officer under President Obama (’09-’12) and in 2014, authored "Innovative State: How New Technologies can Transform Government.” He joined the Board of the Health Care Cost Institute in 2017, earned his MPP from Harvard Kennedy School, and BA from Johns Hopkins University.

Jeanne Cohen founded Motive Medical Intelligence with the vision of leveraging data and technology to create a dynamic, adaptive insight flow across the care continuum. She has led transformational collaborations with global healthcare companies to bring interoperable intelligence solutions to market for the benefit of payers, providers, and patients. Cohen serves on numerous boards and advisory groups in healthcare and higher education. She received her MA from Harvard University and her BA from Bates College.

Jorge Conde is a General Partner at Andreessen Horowitz where he leads investments at the cross-section of biology, computer science and engineering. Prior to joining a16z, Conde served as Chief Strategy Officer for Syros (NASDAQ: SYRS), which is advancing a new wave of medicines that control expression of disease-driving genes to treat cancer and other diseases. He previously served as the company's Chief Financial Officer and Chief Product Officer, leading the platform strategy for Syros' novel gene regulation technology. Conde also cofounded Knome, a human genome interpretation company acquired by Tute Genomics in 2015. Earlier in his career, Conde worked in marketing and operations at MedImmune and as a biotechnology investment banker at Morgan Stanley. He holds an MBA from Harvard Business School, an MS from the Harvard-MIT Division of Health Sciences and Technology, and a BA in Biology from Johns Hopkins University. Conde was named one of the top 35 young innovators in the world by the MIT Technology Review and is a Henry Crown Fellow of the Aspen Institute and a member of the Aspen Global Leadership Network.

Gaurov Dayal, MD, is ChenMed President, New Markets and Chief Growth Officer. Responsible for ChenMed’s national expansion, Gaurov oversees new market operations and has wide-ranging experience in population health, physician group, health plan and hospital operations. Prior to joining ChenMed, Dr. Dayal was a Senior Vice President at Lumeris, where he created and implemented operational solutions for large health care systems and provider groups transitioning to value-based care delivery. Earlier, at SSM Health Care, a large multi-state Integrated Delivery system, Dr. Dayal served as Chief Medical Officer, Interim CEO for SSM Wisconsin Hospitals and President of Health Care Delivery, Finance and Integration. At SSM, he led the transformation from traditional volume-based provider to value-based system, including successful acquisition and integration of Dean Clinic and Dean Health plan- the largest HMO in Southern Wisconsin. He also served as the first Chief Medical Officer for Adventist Health Care and President of the Adventist Medical Group; was founder of a hospitalist group and a strategy consultant for McKinsey and Co. He holds a bachelor’s degree from Johns Hopkins University and earned his doctor of medicine degree from Northwestern University. He was residency training was performed in pediatrics at Washington University in St. Louis.

Carter Dredge is Chief Transformation Officer for SSM Health. He provides executive strategic leadership for SSM Health’s continued transformation from a traditional, fee-for-service system to one focused on creating value and managing the health of populations. Dredge leads the areas of enterprise strategy and planning, business development, advanced analytics, innovation, population health, and value-based care across the organization’s four-state system. Headquartered in St. Louis, SSM Health is a Catholic not-for-profit health system serving communities across the Midwest through a robust and fully integrated health care delivery system. The system includes 23 hospitals, nearly 300 physician offices and other outpatient and virtual care services, 10 post-acute facilities, comprehensive home care and hospice services, a pharmacy benefit company, a health insurance company and an accountable care organization. Dredge became SSM Health’s Chief Transformation Officer in October 2017. Previously, he served as Assistant Vice President and Administrator for Home Care Services at Intermountain Healthcare. Before that, he was the Director of Healthcare Transformation/Population Health at Intermountain, where he led the innovative strategy development for multiple major enterprise clinical and insurance-related functions. Mr. Dredge holds a bachelor’s degree in business management/corporate finance from Brigham Young University, and a Master of Healthcare Administration from Cornell University.

Jeff Eberle is the CEO of Truveris, a company with data-enabled solutions that increase transparency, affordability, and access of prescription drugs. He has more than 20 years of experience in healthcare and technology. Prior to Truveris, Eberle served as COO of Optum Analytics, a provider of analytics, data and services across multiple healthcare markets, and as a founding member of Optum Ventures, focused on investments in digital health companies. He previously was an investment banker at Piper Jaffray and held strategy and business development roles serving payer and provider markets. He earned his MBA from the University of Michigan, and his BA in from the University of Minnesota.

Jesse M. Ehrenfeld, MD, MPH, is chair of the American Medical Association Board of Trustees and the Joseph A. Johnson Jr. Distinguished Leadership Professor at Vanderbilt University in the departments of anesthesiology, surgery, biomedical informatics, and health policy. He is the director of the Vanderbilt Program for LGBTQ Health. His research, which focuses on understanding how information technology can improve health equity and patient outcomes, has led to over 250 abstracts and 200 peer-reviewed manuscripts. A recognized leader, he is also editor-in-chief of the Journal of Medical Systems and has co-authored 18 clinical textbooks. In 2018, he was an inaugural recipient of the NIH Sex and Gender Minority Research Award from the NIH Director. Dr. Ehrenfeld is a graduate of Phillips Academy, Haverford College, the University of Chicago Pritzker School of Medicine, and the Harvard School of Public Health.

Vivek Garipalli is the Co-founder and CEO of Clover Health, a health insurance company leveraging data to proactively improve health outcomes, filling gaps in care and reducing avoidable costs. Prior to founding Clover, Garipalli founded CarePoint Health, a fully integrated healthcare system in New Jersey. Through his role at CarePoint – whose mission is to serve uninsured and underinsured patient populations – Garipalli experienced the misalignment of providers and insurance companies first-hand. Prior to CarePoint, he owned and operated various outpatient facilities. Garipalli is active in health tech, serving as a board member of Flatiron Health and Doctor Evidence.

Julie Papanek Grant leads investments and company formation efforts in biopharma and digital health companies that tangibly improve patient care. Since joining Canaan in 2013, Grant has incubated, financed, and supported investments in multiple new biopharmaceutical companies including Nocion Therapeutics, Protagonist (PTGX), Cellular Research, Dermira, Labrys Biologics, CytomX, Unchained Labs, Chrono Therapeutics, Genome Medical, Glooko, Vineti and Truveris. Prior to joining Canaan, Grant worked at Genentech bringing new oncology products to market. She served on the board of the Biden Cancer Initiative and co-chaired the IT advisory board for Planned Parenthood Northern California. She holds an M.B.A. from Stanford’s Graduate School of Business, a M.Phil. from Cambridge University in BioScience Enterprise and a B.S. in Molecular Biophysics and Biochemistry from Yale University.

In her role as Vice President of Health-System Strategy, Hendrick is responsible for the creation and ongoing strategy of specialty pharmacy solutions developed for health system partners. As part of her responsibilities, she works closely with health system executive teams on strategies for creating and growing hospital-owned specialty pharmacies. Prior to joining Shields Health Solutions, Hendrick was Chief Operating Officer at Emory University Hospital Midtown in Atlanta, Georgia with responsibility for clinical outcomes and operations of ancillary services, ambulatory care and the environment of care. Her past experience includes pharmacy leadership roles within Emory Healthcare, The University of Wisconsin Hospitals and Clinics, HCA and McKesson. She has been highly involved with shaping the profession of health-system pharmacy including serving on the boards of four state pharmacy associations and over 10 years involvement with the American Society of Health-System Pharmacists. She is a Board Certified Pharmacotherapy Specialist and a Fellow of the American Society of Health-System Pharmacists. Henrick earned a Bachelors of Science degree from the University of Wisconsin-Madison, and Doctor of Pharmacy and Master of Science in Health System Pharmacy Administration degrees from The Ohio State University.

Trip Hofer is the CEO of AbleTo, Inc, a leading provider of technology-enabled behavioral health care services. Prior to joining AbleTo, Hofer was responsible for the development and management of CVS/ specialty trend management products and services, while serving as both General Manager of Novologix and President of Accordant Health Services. Prior to joining CVS/ specialty, he held various senior level positions at OptumHealth, a UnitedHealth Group Company, including Chief Operating Officer and General Manager of OptumHealth's Wellness and Well-Being business. Hofer came to UnitedHealth Group from Health Dialogue, where he was responsible for Business Development. He holds a bachelor’s degree in Economics and Environmental Studies, Cum Laude from St. Lawrence University and a Master of Business Administration degree from Yale University's School of Management.

As Executive Vice President of Government Programs and Diversified Business for GuideWell and Florida Blue, Iselin is responsible for the Florida Blue Medicare business, GuideWell Source, GuideWell Connect, PopHealthCare and the enterprise marketing and brand function. She brings to GuideWell more than 20 years of experience in health care strategy, policy, finance and philanthropy in both the private and public sectors. Prior to her current role, she served as Senior Vice President and Chief Strategy Officer for GuideWell and Florida Blue. Before she joined GuideWell and Florida Blue, Iselin was President of Optum Federal, where she led the federal government business, a $300+ million segment with more than 1,000 employees. She also developed the company’s state and federal government business strategy.

Carolyn Jasik, MD, is a board-certified Clinical Informatics physician with experience in both the clinical management of diabetes along with creating digital health solutions for health behavior change. At Omada Health she supports the clinical and research teams to create and test the next generation of diabetes and obesity programming via digital therapeutics. Prior to joining Omada she worked at the University of California, San Francisco (UCSF) where she directed the implementation of the Epic electronic health record, integrated digital health programming into clinical practice, and conducted clinical trials on health technology. Dr. Jasik completed her undergraduate degree in public policy at Princeton University, MD at the University of Chicago, and her research training at UCSF. She continues to practice primary care at UCSF where she is an Associate Professor of Medicine.

John Kao is CEO of Alignment Healthcare, a population health management company that partners with health systems and provider groups across the country to improve the health of seniors. Kao has had a long career committed to the healthcare industry and has served in executive roles at CareMore Medical Enterprises, The TriZetto Group, PacifiCare Health Systems, Secure Horizons USA, and FHP International. Kao believes strongly in the tenets of servant leadership and serves on various boards of non-profit organizations. He received his bachelor’s degree from Santa Clara University and his MBA from UCLA Anderson Graduate School of Management.

David Benshoof Klein is a healthcare investor and entrepreneur with over 18 years life science industry experience; he has played key roles in founding, financing and operating more than 10 life science companies. In 2012, Klein co-founded Click Therapeutics which develops and commercializes software as medical treatments: Digital Therapeutics™. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults. He formerly served as Managing Director at Opus Point Partners, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies. Klein holds a BA from Brandeis University and has been a guest lecturer at Columbia University’s Biotechnology Program.

Michael Krouse joined OhioHealth in March 2007 as Chief Information Officer and was named Senior Vice President in 2011. In December 2015, Krouse assumed responsibility for Lab, Pharmacy, Sterile Processing, Environmental, Nutrition and Patient Transport Services. He also assumed leadership for the organization’s Process Excellence and Project Management teams. In March of 2017, Krouse was named the Senior Vice President and Chief Strategy and Transformation Officer. In this role he provides system leadership for Strategy, Business Development, Market Intelligence and Insights, Regional Development, New Ventures, and Business Transformation. Krouse has been recognized nationally with multiple awards including, the Premier 100 IT Leaders by Computerworld; the HIT Men & Women Innovators Up and Coming Award from Healthcare IT News; the C-Suite Award from Columbus Business First; and CIO 100. He led OhioHealth IT to notable recognitions as Most Wired, Best Places to Work in IT (2009-2017), the achievement of HIMSS Analytics Stage 7 in both the Ambulatory and Acute Care settings and a 9-star performance in Epic’s Star program.

Sean Lane is a lifelong technologist who grew up in a small, rural town in Ohio and started his career in the US intelligence community, holding leadership positions in the Department of Defense and the National Security Agency. He served five combat tours in Iraq and Afghanistan and was awarded the Defense Meritorious Service Medal and Bronze Star Medal for his service. After government service, Lane started his life as an entrepreneur and has founded several technology companies dealing with big data, advanced analytics, entity resolution, and most recently, artificial intelligence. Lane raised over $70M in venture capital and is now a leading expert in applying Al in healthcare. He is a graduate of Miami University with an Honorary Doctorate of Public Service from the University of Rio Grande and was named Ernst and Young Entrepreneur of the Year.

Sarah Marche, PharmD, received her Doctor of Pharmacy from Duquesne University and then completed a Pharmacy Practice residency with University of Pittsburgh. She began her pharmacy career as a Clinical Pharmacist with UPMC - Shadyside Hospital as a Critical Care Pharmacist and also spent time at UPMC – Palermo, working as a pharmacist. Her career in managed care began as a Clinical Pharmacy Specialist at Highmark Inc. in 2005 with a focus on Formulary and Utilization Management for the Commercial and Medicare Part D lines of business as well as Drug Pipeline Management. Dr. Marche was subsequently promoted to Manager of Manufacturer Relations where she served as the main point of contact for pharmaceutical manufacturers and built the rebate contracting strategy for the Pharmacy Services organization at Highmark. She expanded her role to drive the strategy for all vendor partnerships including the PBM and Specialty Pharmacy partners. Dr. Marche became the Vice President of Pharmacy Services in 2014 where she has assumed responsibility for all of Highmark’s Pharmacy Benefit Management Business, including Clinical Pharmacy, Pharmacy Product, Marketing and Sales, Operations, and Manufacturer and Vendor Contracting. She was promoted to Senior Vice President in May 2019.

Jeff Margolis is a recognized healthcare IT leader based on his 30-year track record of applying technologies to address the complex problems facing the healthcare industry. Margolis is currently Chairman and CEO of Welltok, a consumer health enterprise SaaS company. Previously, he founded and served as CEO of TriZetto, the leading healthcare management services company. He led TriZetto through a successful IPO and $1.4B private equity buyout. Margolis serves on boards for non-profit and for profit organizations. As a health futurist and visionary, he is a frequent speaker, guest lecturer and author.

Shawn Morris is a seasoned industry leader focused on building a national organization, delivering operational excellence and transforming the healthcare delivery experience. As Privia Health’s Chief Executive Officer, Morris drives initiatives to meet providers where they are on the transition to value while building strategic partnerships with physicians, health plans, health systems, and employers to better align reimbursements to quality and affordability. Morris was previously the President and Chief Operating Officer of Cigna-HealthSpring, a Cigna company. He was responsible for the financial and operational performance of Cigna’s Medicare Advantage business, one of the largest companies providing private Medicare solutions, that served 1.5 million Medicare customers and generated $8 billion in revenue. He earned a Bachelor of Science in Accounting from Western Kentucky University and is a Certified Public Accountant and Certified Financial Planner. He is an inaugural Fellow of the Nashville Healthcare Council and graduate of Dartmouth College’s Tuck Business School 2030 Global Executive program. Morris is a member of the American Society of CPAs, National Association of Corporate Directors and AMA CEO Advisory Committee.

As president of Joint Venture Markets for Aetna, Nettesheim drives the execution of the business plans for Aetna’s Joint Venture markets with a focus on achieving goals through growth, advancing Aetna’s relationship with the provider and transforming the way care is delivered locally. Previously, Nettesheim was CEO of Aetna’s Accountable Care Solutions organization. She was responsible for the development, growth and performance of Aetna’s value-based care and contracting models including Aetna’s Whole Health (ACO) product portfolio in support of enhancing local population health models. Inherent in these models are the underpinning transformative clinical and care delivery models. Nettesheim earned a master's degree in business administration from the Kellogg School of Management at Northwestern University where she concentrated her studies in health industry management. She received her bachelor of science in economics with a minor in systems engineering from the United States Military Academy and served in the United States Army, departing with the rank of Captain.

A visionary and collaborative health care leader, Janice E. Nevin, M.D., MPH, is president and CEO of Christiana Care Health System. Dr. Nevin is pioneering value-based care, leading a transformation from a health care system to a system that impacts health. She is nationally recognized for innovation in patient/family-centered care and population health.

As Chief Medical Officer of AbleTo, Reena Pande, MD serves as a passionate voice for the need to bridge the gaps between medical health and behavioral health. She spearheads AbleTo’s data analytics and outcomes research. In addition to her work at AbleTo, Pande is a practicing cardiologist at Brigham and Women’s Hospital in Boston, MA and Instructor at Harvard Medical School.

Jana Perry began her duties as Vice President of Strategy and Marketing recently after holding the Vice President of Sales position since 2015. Perry has been with Health Alliance since 1986, serving in a variety of leadership roles for claims, operations, member retention, customer service and Consumer and Employer Group sales and service. In her current role, she has overall responsibility for launching new business strategic partnerships focused on the shift from volume to value. Perry is accountable for development of a marketing strategy that is aligned with the organization’s short-term and long-term strategic plans; and supports the market growth objectives of health system partners. Further responsibilities include assessing market trends and new product developments, applying these findings to the business of Health Alliance and overall responsibility for construction and implementation of product line adjustments.

Dr. Reiss-Brennan is Chief Clinical Science Officer at Alluceo, a digital, team-based care platform integrating patients’ mental and physical health into routine primary care. She is trained as a medical anthropologist and psychiatric nurse practitioner and has worked in primary care for over 35 years. Previously, as a principal investigator at Intermountain Healthcare (IH), she led the adoption, diffusion and evaluation of team based care for mental health and medical care. The IH Mental Health Integration (MHI) program cost and quality evidence has transformed primary care culture and has spread rapidly over 90 IH medical clinics including uninsured, rural and specialty, as well as 45 non-IH community clinics throughout the United States. MHI provides team-based culture for the advancement of the medical home which supports the shared accountability driven by US health reform. Dr. Reiss-Brennan also holds a longstanding faculty appointment at the University of Utah, College of Nursing. In addition, she serves as a local, national and international expert on the cultural innovation and implementation of MHI research, including cost, quality and patient and staff experience, to improve patients’ mental and physical health.

Bob Robke heads the Professional Services and Business Development teams within 2bPrecise. His teams work with clients to streamline implementations and to scale the Precision Medicine across their organization. In addition, Robke works within the industry to find partners that contribute to the overall mission of 2bPrecise. Prior to 2bPrecise, Robke served ten years as Cerner's Vice President of Interoperability.

Duane Elliott Reynolds is the newly appointed President and CEO of the Institute for Diversity and Health Equity. He will lead the Institute’s efforts to reduce healthcare inequities and advance diversity and inclusion across the healthcare field. Recently, he served as Chief for Diversity and Inclusion and Director of Consulting at Optum/UnitedHealth Group by way of acquisition of the Advisory Board Company. Under his leadership, the organization launched new practice areas focused on addressing health inequities, the social determinants of health and inclusion within healthcare payer and provider organizations. He also spearheaded the development of the company’s LGBTQ business resource group. Previous experience also includes Johns Hopkins Medicine in Baltimore and Emory Healthcare in Atlanta. Reynolds was recognized as a “Healthcare Up and Comer” by Modern Healthcare in 2018.

Pam Roesch, MPH, joined SUHI in March 2017 to assist with the dissemination of findings from the Sinai Community Health Survey 2.0. In addition, she helps manage SUHI’s relationship with Chicago Medical School, directing SUHI’s summer and year-long internship programs for CMS students. Roesch also helps support the NIH-funded Improving Sickle Cell Care in Adolescents and Adults in Chicago (ISAAC) project, which aims to address the unique health needs of individuals living with sickle cell disease in the city.

A legend and leader in the hotel world, Horst Schulze's teachings and vision have reshaped the concepts of service and hospitality across industries. Schulze's professional life began over 65 years ago as a server's assistant in a German resort town. Throughout the years he worked for both Hilton Hotels and Hyatt Hotels Corporation before becoming one of the founding members of The Ritz Carlton Hotel Company in 1983. There Schulze created the operating and service standards that have become world famous. At The Ritz Carlton, Schulze served as President and COO responsible for the $2 billion operations worldwide. It was under his leadership that The Ritz Carlton Hotel Company was awarded the prestigious Malcolm Baldrige National Quality Award- twice- making it the first and only hotel company to ever win even one. In 1991, Schulze was recognized as "corporate hotelier of the world" by HOTELS Magazine. In 1995, he was awarded the Ishikawa Medal for his personal contributions to the quality movement. In 1999, Johnson & Wales University gave him an honorary Doctor of Business Administration degree in Hospitality Management. Most recently, Schulze has been honored as a “Leader in Luxury” by Travel Agent Magazine and its sister publication Luxury Travel Advisor. After leaving The Ritz Carlton Hotel Company, Schulze went onto found The Capella Hotel Group. This luxury hotel company managed some of the most elite properties worldwide, receiving countless awards and recognitions. Today, Schulze serves on various boards and acts as a consultant across industries. He is currently completing his seminal book on creating excellence.

Rina Shah is Group Vice President of Specialty & Retail Pharmacy at Walgreens. She began her career at Walgreens in 1998 in our stores where she held various pharmacy roles. In 2007, Shah joined the corporate support center where she held multiple leadership positions in which she was responsible for launching innovative healthcare initiatives across the organization, overseeing retail and local specialty pharmacies, and leading sales operations and client services within market access. In her current role, she leads a team that is responsible for pharmacy operations, services and specialty across 9,000+ Walgreens pharmacies. Shah received her Doctorate in Pharmacy from the University of Illinois in Chicago in 2005.

A Rite Aid veteran who’s spent more than two decades with the company, Staniforth is currently senior vice president, pharmacy and oversees Rite Aid’s pharmacy operations, government and regulatory affairs, clinical services, pharmacy initiatives, health plan solutions and Health Dialog’s operations. Prior to this role, Staniforth was senior vice president, business integration where she led planning efforts and transaction services for Rite Aid’s asset purchase agreement with Walgreens Boots Alliance. In 2014, Staniforth was promoted to chief operating officer of Health Dialog, where she was responsible for executing the strategic vision and managing day-to-day operations of the company. Staniforth started her career in pharmacy as a pharmacist in Johannesburg, South Africa. She later joined Sandoz, now a part of Novartis Pharmaceuticals, overseeing retail sales operations for the company in Cape Town, South Africa. She subsequently joined Rite Aid after moving to the United States. During Staniforth’s tenure with Rite Aid, she has continued to take on roles of increasing leadership and operating responsibility, including regional pharmacy vice president, division pharmacy vice president and group vice president of pharmacy initiatives and clinical services. She is a pharmacy graduate of Witwatersrand Technikon, Johannesburg, South Africa.

Angela Taylor is the Wellness Coordinator for the Garfield Park Community Council (GPCC), where she manages the 32-member Garfield Park Garden Network and the Garfield Park Neighborhood Market. Each summer, Taylor works with up to ten local youth through the Youth Garden Corps, a paid internship program in which teens work in local gardens and gain horticultural and job readiness skills. She also plans and organizes additional wellness projects throughout the year, including healthy block parties through the PlayStreets program and violence prevention events through the Communities Partnering 4 Peace coalition. A lifelong Garfield Park resident, Taylor has taken a leadership and organizing role in her community’s renewal efforts. She serves on the Tilton Park Advisory Council and The Hatchery Community Advisory Council. In addition to her work in Garfield Park, She is a board member of Chicago Community Gardeners Association and Advocates for Urban Agriculture, an affiliate of NeighborSpace, and a retiree of the Illinois Department of Human Services. With her family, she manages an award-winning garden, the Fulton Street Flower and Vegetable Garden, one of the original sites of the Garden Network.

Grace Terrell, MD is President and CEO of Envision Genomics, a company focused on the integration of precision medicine technology into population health frameworks for patients with rare and undiagnosed diseases and Chief Clinical Strategy Office for Kailos Genetics, a pharmacogenetics company. She is a national thought leader in healthcare innovation and delivery system reform, and a serial entrepreneur in population health outcomes driven through patient care model design, clinical and information integration, and value-based payment models. She is the former CEO of Cornerstone Health Care, one of the first medical groups to make the “move to value” by lowering the cost of care and improving its quality for the sickest, most vulnerable patients, and the founding CEO of CHESS, a population health management company. Dr. Terrell currently serves on the US DHHS’ Physician-Focused Payment Model Technical Advisory Committee, the board of the AMGA, and is an Oliver Wyman Senior Advisor.

Jill S. Tietjen, PE, is an author, national speaker, and an electrical engineer. After 40 years in the electric utility industry, her professional focus is now on women’s advocacy, worldwide. A former blogger for The Huffington Post, she speaks nationally on the accomplishments of women, nominates women for awards, and continues to write books (9 published to date), following in the footsteps of her bestselling and award-winning book, Her Story: A Timeline of the Women Who Changed America (written with Charlotte Waisman). She is a frequent keynote speaker as her positive energy and her ability to relate to the audience result in inspired and energized listeners. The recipient of many awards, her induction into the Colorado Women’s Hall of Fame in 2010 remains one of her most treasured.

Todd Van Tol is the Senior Vice President of Health Care Value for Blue Cross Blue Shield of Michigan (BCBSM). In that role, he has responsibility for provider contracting and network management, medical and pharmacy management, as well as wellness programs and product development across all lines of business for BCBSM. Previously, he led the plan’s Commercial Group business with responsibility for the Autos, Key & Large, Middle & Small Group, and Private Exchange lines of business. Prior to joining BCBSM in July of 2017, Van Tol served as a Partner and North American practice leader for the Health & Life Sciences business of Oliver Wyman where he led the firm’s efforts across Payer and Provider clients. His experience spans a broad range of strategic issues facing health plans and providers including market reform planning, customer strategy, building new value-based payer/provider partnership models, and the development of next-generation product offerings.

Kurt Waltenbaugh is a serial entrepreneur with a career focused on the consumer: using data to predict and influence behavior. Understanding consumer behavior, Waltenbaugh has built successful analytic solutions, products and companies in the healthcare, retail, education, and credentialing industries. His previous companies were sold to Oracle and Pearson Education. Most recently, he was responsible for product strategy at Optum, Inc. (UnitedHealth Group), building data analytic businesses for the provider, payer, and employer markets. When not working with customers, he is with his wife, guiding their three children toward adulthood, and planning their next winter camping trek into Minnesota's Boundary Waters (BWCAW).

Chris Waugh is Sutter Health’s first chief innovation officer. In this role, he uses his extensive experience in human-centered design to guide Sutter’s enterprise innovation strategy. He and his team are developing and managing the organization’s innovation portfolio and refining and expanding its innovation processes. Waugh brings unique and inventive approaches to benefit patients across Sutter Health’s network. He is widely recognized for inspiring audiences and bringing together people from multidisciplinary teams. His innovation team serves as the entry point for external partners to connect with Sutter Health, providing an avenue for innovators to present ideas that can improve our health delivery processes. Waugh has a decade of entrepreneurial leadership experience at IDEO, the Bay Area design and innovation consulting firm. He also served as vice president of design at San Francisco’s One Medical Group, where he helped create a culture of innovation. He is a graduate of Fort Lewis College in Colorado, with degrees in international business and French.

Huntington Willard, PhD is Director & Principal of Geisinger National Precision Health, a commercial unit based in North Bethesda, Maryland.  In this role, he leads efforts to engage with health systems and other institutions around the country, providing support and services to develop patient-focused programs that bring genomics and health care together.  

Trenor Williams, MD, is a family physician, entrepreneur, former health system executive and consulting leader. He is founder and CEO of Socially Determined where he is responsible for developing the overall company vision, leading fundraising activities with strategic investors, and providing executive oversite for all commercial clients. He began his career as the Medical Director of Family Practice at Mammoth Hospital in California and went on to serve as Lieutenant Commander in the United States Naval Reserve. His experience includes leadership roles at Healthlink and Deloitte. In 2008, Williams founded Clinovations, a strategic healthcare consulting firm, and served as CEO. He was responsible for leading and implementing a clinical healthcare IT strategy for a nine-hospital health system. He also developed and implemented strategies for integrating national and state health policies into organizational IT and quality initiatives. Williams sold the company to the Advisory Board Company (ABCO) in 2014 and stayed as Managing Partner in the Consulting and Management division until 2016. Williams holds a Bachelor of Science in Biology from Virginia Polytechnic Institute and received his Medical degree from Marshall University.

Laura Yecies is the CEO of SyncThink, a world leader in neurotechnology and brain health analytics and creators of the award-winning EYE-SYNC brain health assessment tool. A Silicon Valley veteran, she has successfully led multiple startups and top brands. Yecies was previously the CEO of two venture-backed startups. As CEO of Catch.com she helped develop the company's business model expanding the product footprint and built strategic alliances, and then successfully sold the company to Apple in 2013. She joined SugarSync as CEO and led the company for four years through an aggressive business and product growth phase growing from zero to $25M in revenue and signed several strategic partnerships. SugarSync was later acquired by J2Global. Yecies was the Vice President of the Netscape browser division at AOL responsible for the development of Netscape 7.0 and the launch of the Netscape browser in 23 languages. After leaving Netscape, she joined Yahoo where she served as the Global General Manager for Yahoo Mail. Yecies received her MBA from Harvard and an MSFS from the Georgetown School of Foreign Service. She received her A.B. Magna Cum Laude in Government from Dartmouth. She’s been the recipient of many awards such as the 2011 Gold Medal and 2012 Silver Medal for Female Executive of the Year for the Stevie Award for Women in Business, the Inc. 500 — Top Female CEO of 2012, and was a previous U.S. Department of State TechWoman Mentor.

Value-based healthcare—everyone is trying to reach this “holy grail,” and there’s no more critical component than the primary care physician. But as we all know, it's not that easy. Moving primary care to value, at scale, continues to present significant challenges. In this session, we will explore various models that seek to move primary care from fee-for-service to value and discuss how they've overcome some challenges typically faced in the shift to value.

Behavioral health is hot. As an industry, we have recognized the positive impact of diagnosing and treating mental health conditions appropriately—and, the consequences of when we’re not. For patients, seeking routine medical care can already be a disjointed and overwhelming experience, and underlying behavioral health problems can dramatically exacerbate illness and care cost. However, innovative, new models focused on integrating behavioral health treatment into care models are driving meaningful outcomes for patients. In this session, we'll explore some of those models and learn how they're creating differentiated value.

The booming digital therapeutics space is at the cutting edge of redefining how care is provided through technology. As the supply of digital therapeutics expands—through the proliferation of innovators—how do we think about the practical application and adoption of digital therapeutics? In this session, we will contextualize the role of digital therapeutics and their implications on the broader healthcare ecosystem through the lens of three innovative organizations.

Specialty pharmacy spend is on the rise and it is the single biggest driver of increasing medical costs, but how do you crack this highly heterogeneous problem? To understand the specialty pharmacy problem, we must first peel back the onion and understand what approaches will be successful in the ever-evolving and increasing landscape of specialty pharmaceutical drugs—and then customize the approach based on that understanding. In this session, we'll hear from constituents across the supply and value chains who are leveraging different mechanisms to make these high costs drugs sustainable in the long run for the overall healthcare environment.

Only 15 percent of what we know about consumers resides within the healthcare ecosystem—and many posit that it's the other 85 percent that is much more impactful for care decisions. The amount of consumer information available continues to rapidly grow, leaving tremendous value on the table. How do you overcome the complex barriers to tactically bring the multitude of data sources together and harness its power in an action-oriented way? Join us as we deep dive into several case studies where a pair of organizations is harnessing the combination of consumer and healthcare data to drive meaningful impact on consumer behavior, engagement, and outcomes.

The traditional network paradigm is changing, as consumers increasingly demand better value for their money and broad variety in network options. At the same time, innovators have introduced new models for care delivery into the market evolving the front door of care. Payers now face a bifurcated set of network demands, how do they navigate legacy networks and relationships while meeting demand for innovative, personalized networks? What role might new entrants play? And, how might we reconsider our very understanding of networks?

By 2030, 20 percent of the US population will be 65 or older. With a rising proportion of aging Baby Boomers buying Medicare Advantage, it represents the single biggest and most lucrative growth segment. For years, CMS has spearheaded the bulk of innovation in MA. We go beyond the brass tacks of Stars and Risk Adjustment to talk about what it will take to win in the next generation of Medicare Advantage. We will have an in-depth conversation with leaders in the space who are using different models to support their v2.0 of MA.

The promise and power of precision medicine has at last crossed over the intersection of price and utility – moving from ‘fascinating’ to ‘effective’ in a series of key markets. Full genome sequencing may soon be available at affordable pricing and commercially viable for mass application. Learn why precision medicine matters and what it takes to get started from three leaders who share their perspectives – and challenges – in operationalizing precision medicine for care delivery.